 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Centro de Investigação em Saúde de Manhiça (CISM) |
| Street 1: | Rua 12 |
| Street 2: | Cambeve |
| City: | Manhiça |
| Province: | Maputo |
| Post Code: | 1929 |
| Country: | Mozambique |
| Phone: | +258 866575707 |
| Organization Email: | eusebio.macete@manhica.net |
| Web Site: | http://www.manhica.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Foundation |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Foundation |
| Organization Type - Secondary: | Private Foundation |
| Organization Description: | |
| The Manhiça Health Research Centre (Centro de Investigação em Saúde de Manhiça, CISM) was created in 1996 to promote and conduct biomedical research in priority health areas. Since its creation, the Centre has been developing its activities under a bilateral cooperation programme between the Governments of Mozambique and Spain, and with the support of the Hospital Clínic / Universitat de Barcelona (through the Fundació Clínic per a la Recerca Biomèdica). 1. MISSION To conduct biomedical research in health priority areas to protect and improve the population’s health Our vision is to be a center of excellence in biomedical research that generates evidence to guide public health policy countries in the world 2. TB is one of the most important public health issues in the country and as such, we try to come up with new tools to fight TB. 3. WE conduct clinical trials in the fields of drug and vaccine development as well as participate in studies of new diagnostics for TB. We also conduct epidemiological research to better characterize and quantify TB in the district of Manhiça, southern Mozambique. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We conduct biomedical research which provides operational data that can be used by the NTP for policy making. | |
Geographical Reach | |
| Which country is your headquarters located in: | Mozambique |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Mozambique |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: We conduct drug resistance surveys to monitor drug resistance in our district TB-HIV: We do epidemiological studies on TB HIV coinfected patients. 75% of our patients are HIV co infected Laboratory Strengthening: We have participated in EDCTP projects which aimed at strenghtening and equipping our laboratory to offer better TB diagnosis services New Diagnostics: We participate in studies to come up with improved diagnostic tests for TB diagnosis New TB Drugs: We have participated and participate in different drug clinical trials New TB Vaccines: We have participated in AERAS 402 vaccine trial in 2010-2013. Research: Any of the above fields is tackled from the research point of view. Research is our main focus. |
|
Declaration | |
| Declaration of interests: We have no conflicts of interest | |
| Application date: | August 3, 2016 |
| Last updated: | August 17, 2016 |